Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
Single arm, open label, Phase IB study of indibulin capsules in subjects with advanced solid
tumors; eligible subjects will have a baseline PET scan showing a standardized uptake value
(SUV) of ≥5.0 in ≥1 lesion on an 18F-FDG (fluorine-18-labeled deoxyglucose) scale.